Search clinical trials for: moderate cGVHD

Total 5953 results

Stefanie Sarantopoulos, MD, PhD.
National Institutes of Health (NIH); Incyte Corporation; Rigel Pharmaceuticals

Not yet recruiting

Ruxolitinib Plus Fostamatinib for Steroid Refractory cGvHD

Chronic Graft Versus Host Disease

United States
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Phase II Study of Moderate-dose Hypofractionated RT Combined With Tislelizumab for HCC With Diffuse Tumor Thrombosis

Hepatocellular Carcinoma | Radiotherapy | Tislelizumab | Tumor Thrombosis

China
Takeda

Recruiting

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

Crohn's Disease

United States, Australia, France, Taiwan, Hungary, Korea, Republic of, Spain, Switzerland, China, Japan, Belgium, Canada, Germany, Italy, Poland, Romania, United Kingdom, Czechia, Denmark, Greece, Norway, Slovakia, Netherlands
Riphah International University

Recruiting

Effect of 8 Weeks Moderate & High Intensity Training on Cognitive Functions and Sleep of Female Students

Sleep | Cognition

Pakistan
Xijing Hospital

Recruiting

Transcutaneous Electrical Acustimulation in the Treatment of Mild to Moderate Ulcerative Colitis

Ulcerative Colitis

China
Morphic Therapeutic, Inc

Recruiting

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease (GARNET)

Inflammatory Bowel Diseases | Crohn's Disease

United States, Poland, Georgia, Slovakia, Romania, Croatia, Germany, Spain
Medical University of South Carolina

Not yet recruiting

Weekly Isotretinoin vs Tetracycline for Moderate Acne

Acne Vulgaris
McMaster University
Center for Medicinal Cannabis Research

Not yet recruiting

Psilocybin in the Treatment of Cannabis Use Disorder: A-Proof-of-Concept Study (PSI_CUD)

Cannabis Use Disorder, Moderate | Cannabis Use Disorder, Severe
Sanofi

Recruiting

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids (SHORE)

Dermatitis Atopic

Japan, Chile, Canada, Argentina, Brazil, France, United States, Turkey, China
Amgen

Recruiting

A Study With Self-administered Rocatinlimab in Adolescent and Adult Participants With Moderate-to-severe AD (ROCKET-Outpost)

Atopic Dermatitis

United States, Canada
Janssen Research & Development, LLC

Recruiting

A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2)

Plaque Psoriasis

United States, Korea, Republic of, Taiwan, Germany, Poland, Brazil, Spain, Hungary, Australia, Canada, Romania
Northeastern University
Brandeis University

Recruiting

Walking After Traumatic Brain Injury in Older Adults

Traumatic Brain Injury | Mild Traumatic Brain Injury | TBI | Moderate Traumatic Brain Injury

United States
University of Georgia

Recruiting

Comparative Analysis of Biomarkers in Response to Acute Moderate-Intensity Activity

Biomarkers | Aerobic Exercise | Acute Exercise

United States
Guangdong Provincial People's Hospital

Recruiting

Short-term Effects of Preoperative Exercise in Moderate-to-high Perioperative Risk Lung Cancer Patients (PRE-EXELUCA)

Lung Cancer

China
Washington University School of Medicine
Kamuzu University of Health Sciences; Project Peanut Butter; Balchem Corp

Recruiting

Choline to Prevent SAM in Children With MAM (CHOP-MAM)

Moderate Acute Malnutrition

Malawi
Lakehead University

Recruiting

Over-the-Counter Antihistamines & Heat Stress

Allergic Rhinitis | Heat Illness | Heat Injury | Sudomotor Sympathetic Dysfunction

Canada
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

A First-in-human, Single-ascending-dose Study of IBI3002 in Healthy Participants and Mild to Moderate Asthmatics

Asthma | Healthy Participants

Australia
Incyte Corporation

Recruiting

A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa (STOP-HS LTE)

Hidradenitis Suppurativa (HS)

United States, Austria, Belgium, Germany, Poland, Spain, Australia, Denmark, France, United Kingdom, Canada, Japan, Bulgaria, Netherlands, Czechia, Greece, Italy
Assistance Publique Hopitaux De Marseille

Not yet recruiting

Effects on Biotrauma of NMBAs and PP Association During ARDS (CURA-PRONE)

Moderate to Severe Acute Respiratory Distress Syndrome

France
St. Mary's University, Twickenham

Not yet recruiting

Caffeine and Training Intensity Quantification

Caffeine
Overcome

Recruiting

Cracking the Code to Better Sleep: A Pioneering Study on Remote Support for Insomnia Relief

Insomnia

United Kingdom
Fidia Farmaceutici s.p.a.

Recruiting

Assessment of Efficacy and Safety of the Use of Two Eye Gel Products Containing 5% Dexpanthenol in Patients With Moderate to Severe Dry Eye Syndrome

Dry Eye Disease

Italy
University Ghent

Recruiting

The Effects of a Moderate Intensity Training Program Versus a High Intensity Training Program on Central Pain Processing (ChronicPA-PAIN)

Healthy

Belgium
Chess Mobile Health
National Institute on Drug Abuse (NIDA); Western Michigan University

Not yet recruiting

Mobile Technologies Extending Reach of Primary Care for Substance Use Disorders

Substance-Related Disorders
Third Affiliated Hospital, Sun Yat-Sen University

Not yet recruiting

The Therapeutic Effect of Different Exercise Intensities on Weight Loss in Obese Children

Weight Loss | Obese Children and Adolescents
Danone Specialized Nutrition Indonesia

Recruiting

Tolerance of Extensive Hydrolyzed Whey Protein Milk Among Infant With Mild to Moderate CMPA (PEACE)

Mild to Moderate Cows' Milk Protein Allergy

Indonesia
JHM BioPharma (Tonghua) Co. , Ltd.

Recruiting

A Phase I/II, Randomized, Double-blind, Placebo, and Active Controlled Clinical Study to Evaluate the Safety, Tolerability, Immunogenicity, and Preliminary Efficacy of JHM03 in Subjects With Moderate to Severe Glabellar Lines

Moderate to Severe Glabellar Lines

China
Ascletis Pharmaceuticals Co., Ltd.

Recruiting

A Study to Evaluate the Safety and Efficacy of ASC40 (Denifanstat) Tablets in the Treatment of Patients With Moderate to Severe Acne Vulgaris

Acne

China
Taipei Hospital, Ministry of Health and Welfare

Recruiting

Repeated Transcranial Magnetic Stimulation in the Elderly With Cognitive Impairment

Dementia | Cognitive Impairment, Mild

Taiwan
NKGen Biotech, Inc.

Recruiting

Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease

Moderate Alzheimer Disease

United States
Abbisko Therapeutics Co, Ltd

Recruiting

A Phase II Study Evaluating the Efficacy and Safety of ABSK021 (Pimicotinib)) in the Treatment of cGvHD Chronic Graft Versus Host Disease (cGvHD)

cGvHD

China
NeuroSense Therapeutics Ltd.

Recruiting

A Phase 2, Randomized, Prospective Double-Blind, Single-Center, Placebo-controlled Study to Evaluate Safety, Tolerability, Target Engagement, and Efficacy of PrimeC in Patients With Mild to Moderate Alzheimer's Disease. (RoAD)

Alzheimer Disease

Israel
Ascentage Pharma Group Inc.
Suzhou Yasheng Pharmaceutical Co., Ltd.

Not yet recruiting

A Study of APG-2575 in Patients With Mild-to-moderate Systemic Lupus Erythematosus.

SLE

China
Boston Medical Center

Recruiting

The Impact of Prehabilitation (Prehab)

Post Operative Complications

United States
Sanofi

Recruiting

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2)

Dermatitis Atopic

Argentina, Japan, China, Bulgaria, Czechia, Spain, United States, South Africa, United Kingdom, Portugal, Denmark, Sweden, Turkey, Italy
Eli Lilly and Company

Recruiting

A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis

Plaque Psoriasis

United States
Johns Hopkins University
Thrasher Research Fund; University of North Carolina Project- Lilongwe, Malawi

Not yet recruiting

Oxygen Therapy for Children With Moderate Hypoxemia in Malawi (NoGoLoo)

Pneumonia

Malawi
Seoul National University Hospital

Recruiting

Rezum for 30-80ml Patients With Moderate-severe LUTS to Study Surgical Principles for Median Lobe Enlargement

Prostatic Hyperplasia of the Medial Lobe

Korea, Republic of
Faes Farma, S.A.

Not yet recruiting

Phase III Multicentre Trial of Oral Mesalazine in Patients With Mild to Moderate Ulcerative Colitis.

Colitis, Ulcerative
Mabwell (Shanghai) Bioscience Co., Ltd.

Recruiting

Study to Evaluate the Pharmacokinetic Characteristics, Safety, Tolerability, and Preliminary Efficacy of 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD).

Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

China
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...

Recruiting

Evaluation of 611(Recombinant Humanized Anti-interleukin-4 Receptor Alpha IgG4 Monoclonal Antibody) in Chinese Adults With Moderate to Severe Atopic Dermatitis

Dermatitis, Atopic

China
St. Antonius Hospital

Recruiting

Future Optimal Research and Care Evaluation - Aortic Stenosis (FORCE-AoS)

Severe Aortic Valve Stenosis | Moderate Aortic Valve Stenosis

Netherlands
Beijing Tide Pharmaceutical Co., Ltd

Not yet recruiting

TDI01 Suspension in the Treatment of Chronic Graft-versus-host Disease (cGVHD))

GVHD, Chronic
Shanghai Yueyang Integrated Medicine Hospital

Not yet recruiting

The Relationship Between Moderate-to-severe Psoriasis and Sleep Disturbance

Moderate-to-severe Psoriasis

China
University of Central Florida
American College of Sports Medicine

Recruiting

Dose-Response Effect Exercise and Depression

Depression

United States
Keymed Biosciences Co.Ltd

Not yet recruiting

Study of CM310 in Children Subjects With Moderate-to-severe Atopic Dermatis

Atopic Dermatitis
Xuanwu Hospital, Beijing
Danyang Huichuang Medical Equipment Co., Ltd.

Recruiting

Transcranial Near-infrared Light Therapy for Mild-Moderate Alzheimer's Disease

Alzheimer Disease

China
Guangzhou JOYO Pharma Co., Ltd
Chengdu JOYO pharma Co., Ltd.

Not yet recruiting

A Study to Evaluate JYP0061 Tablets in Patients With Moderate-to-severe Atopic Dermatitis

Moderate-to-severe Atopic Dermatitis
University of California, San Francisco

Not yet recruiting

Preoperative Prophylactic Antibiotic Duration in Moderate to High Risk Ureteroscopy

Nephrolithiasis | Infections, Urinary Tract

United States
Southwest Hospital, China
Xinqiao Hospital of Chongqing

Recruiting

Treatment of Oral Chronic Graft-versus-host Disease With Human Umbilical Cord Mesenchymal Stem Cell Dressing

Mesenchymal Stem Cells

China

Search clinical trials for: moderate cGVHD

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hungary

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations